Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2010

Feb 19, 2010

32566_dirs_2010-02-19_b98325e4-5718-477f-8ec1-7ad2dfe14ac4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-02-18

Reporting Person: Capone Mark Christopher (Chief Operating Officer, MGL)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-18 Common Stock M 5000 $7.27 Acquired 40454 Direct
2010-02-18 Common Stock M 2000 $8.63 Acquired 42454 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-18 Incentive Stock Option (right to buy) $7.27 M 5000 Disposed 2015-09-14 Common Stock (5000) Direct
2010-02-18 Incentive Stock Option (right to buy) $8.63 M 2000 Disposed 2016-02-16 Common Stock (2000) Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.